Netscientific

NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society. NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand. NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation. NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
Type
Public
HQ
London, GB
Employees
23 (est)
Netscientific has headquartered in London, GB

Key People at Netscientific

Farad Azima

Farad Azima

CEO
Michael Boyce-Jacino

Michael Boyce-Jacino

COO

Netscientific Locations

London, GB

Netscientific Metrics

Netscientific Summary

Market capitalization

£33.2 M

Closing share price

£0.65
Netscientific's latest market capitalization is £33.2 M.

Netscientific Financials

Netscientific's revenue was £78.6 K in FY, 2015 which is 55.77% decrease from the previous period.
FY, 2013FY, 2015

Revenue

£178 K£78.6 K

Cost of sales

£6.45 K

Gross profit

£72.1 K

Gross profit Margin, %

91.8%

Operating expense total

£11.5 M

Netscientific Market Value History

100% of current employees of Netscientific are male.

Netscientific Company Life

You may also be interested in